Form 8-K - Current report:
SEC Accession No. 0001213900-24-070285
Filing Date
2024-08-16
Accepted
2024-08-16 16:35:55
Documents
19
Period of Report
2024-08-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0211482-8k_citius.htm   iXBRL 8-K 55459
2 AMENDED AND RESTATED SHARED SERVICES AGREEMENT, DATED AUGUST 12, 2024, BETWEEN C ea021148201ex10-1_citius.htm EX-10.1 82836
3 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT, DATED AS OF AUGUST 12, 2024 ea021148201ex10-2_citius.htm EX-10.2 161930
4 SIDE LETTER AGREEMENT, DATED AUGUST 12, 2024, BY AND BY AND AMONG CITIUS PHARMAC ea021148201ex10-3_citius.htm EX-10.3 31510
5 PROMISSORY NOTE, DATED AUGUST 16, 2024, ISSUED TO CITIUS PHARMACEUTICALS, INC. B ea021148201ex10-4_citius.htm EX-10.4 18002
6 PRESS RELEASE DATED AUGUST 12, 2024 ea021148201ex99-1_citius.htm EX-99.1 23525
7 GRAPHIC ex99-1_001.jpg GRAPHIC 14501
  Complete submission text file 0001213900-24-070285.txt   640687

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE ctxr-20240812.xsd EX-101.SCH 3027
9 XBRL LABEL FILE ctxr-20240812_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE ctxr-20240812_pre.xml EX-101.PRE 22367
21 EXTRACTED XBRL INSTANCE DOCUMENT ea0211482-8k_citius_htm.xml XML 3681
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 241217188
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)